Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
0.7610
-0.0414 (-5.16%)
At close: May 13, 2025, 4:00 PM
0.8298
+0.0688 (9.04%)
Pre-market: May 14, 2025, 9:01 AM EDT
CNTB Employees
Connect Biopharma Holdings had 62 employees as of December 31, 2024. The number of employees decreased by 19 or -23.46% compared to the previous year.
Employees
62
Change (1Y)
-19
Growth (1Y)
-23.46%
Revenue / Employee
$419,887
Profits / Employee
-$252,065
Market Cap
42.12M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62 | -19 | -23.46% |
Dec 31, 2023 | 81 | -19 | -19.00% |
Dec 31, 2022 | 100 | -8 | -7.41% |
Jan 1, 2022 | 108 | 46 | 74.19% |
Dec 31, 2020 | 62 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CNTB News
- 1 day ago - Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma - GlobeNewsWire
- 20 days ago - Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference - GlobeNewsWire
- 6 weeks ago - Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart - GlobeNewsWire
- 6 weeks ago - Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled Asthma - GlobeNewsWire
- 6 weeks ago - Connect Biopharma Reports 2024 Full-Year Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Connect Biopharma Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement - GlobeNewsWire
- 2 months ago - Connect Biopharma to Present at Two Upcoming Investor Conferences - GlobeNewsWire
- 7 months ago - Attovia Therapeutics Appoints Chief Financial Officer - GlobeNewsWire